Pancreatic cancer is a difficult-to-treat cancer. Despite the fact that it is a rare cancer and ranks 12th in frequency among cancers in the United States, it ranks fourth as a cause of cancer deaths in the United States. The median survival duration after diagnosis is around 6 months, and a 5-year survival rate of about 8%. The inadequacies of the treatment to completely cure cancer has made research for the treatment of pancreatic cancer important.